A concomitant increase in CD8+ T cells with an exhausted phenotype is also observed following CTLA‐4 blockade, and combinatorial inhibition of other immune checkpoints (see below) can harness the potential of this expanded population for improved tumor immune control. The gene discussed is CD8A; the disease is neoplasm.